MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY AFTER NINE MONTHS OF FOLLOW-UP: A RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Gonzalez, Enrique J. Alvirez [1 ]
Daryanani, Andres E. [1 ]
Collantes-Hoyos, Diana B. [1 ]
Ricaurte-Carmona, Carolina [1 ]
Garcia, Eduardo Tellez [1 ]
Gomez, Maria [1 ]
Paludo, Jonas [1 ]
Rosenthal, Allison [1 ]
Villarraga, Hector R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1117-03
引用
收藏
页码：2376 / 2376
页数：1
相关论文
共 50 条
  • [21] Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
    Cordeiro, Ana Costa
    Durisek, George
    Batista, Marjorie Vieira
    Schmidt, Jayr
    de Lima, Marcos
    Bezerra, Evandro
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy
    Zurko, Joanna C.
    Epperla, Narendranath
    Nizamuddin, Imran
    Torka, Pallawi
    David, Kevin A.
    Ollila, Thomas A.
    Hess, Brian T.
    Cohen, Jonathon B.
    Ferdman, Robert
    Liu, Jieqi
    Chowdhury, Sayan Mullick
    O'Shea, Kaitlyn
    Romancik, Jason
    Bhansali, Rahul
    Harris, Elyse
    Sorrell, Mckenzie
    Masel, Rebecca
    Fitzgerald, Lindsey
    Galvez, Carlos
    Ma, Shuo
    Winter, Jane N.
    Pro, Barbara
    Gordon, Leo I.
    Danilov, Alexey V.
    Stephens, Deborah M.
    Shah, Nirav N.
    Shouse, Geoffrey
    Kenkre, Vaishalee P.
    Barta, Stefan K.
    Karmali, Reem
    BLOOD, 2021, 138
  • [23] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Iqbal, Madiha
    Jagadeesh, Deepa
    Chavez, Julio
    Khurana, Arushi
    Rosenthal, Allison
    Craver, Emily
    Epperla, Narendranath
    Li, Zhuo
    Isufi, Iris
    Awan, Farrukh T.
    Dholaria, Bhagirathbhai R.
    Maakaron, Joseph E.
    Sandoval-Sus, Jose D.
    Mishra, Rahul
    Saha, Aditi
    Annunzio, Kaitlin
    Bhaskar, Shakthi T.
    Sumransub, Nuttavut
    Fijalka, Andrew
    Ivanov, Stanislav A.
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 211 - 216
  • [24] Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
    Madiha Iqbal
    Deepa Jagadeesh
    Julio Chavez
    Arushi Khurana
    Allison Rosenthal
    Emily Craver
    Narendranath Epperla
    Zhuo Li
    Iris Isufi
    Farrukh T. Awan
    Bhagirathbhai R. Dholaria
    Joseph E. Maakaron
    Jose D. Sandoval-Sus
    Rahul Mishra
    Aditi Saha
    Kaitlin Annunzio
    Shakthi T. Bhaskar
    Nuttavut Sumransub
    Andrew Fijalka
    Stanislav A. Ivanov
    Yi Lin
    Mohamed A. Kharfan-Dabaja
    Bone Marrow Transplantation, 2024, 59 : 211 - 216
  • [25] Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma
    Stock, Sophia
    Bucklein, Veit L.
    Blumenberg, Viktoria
    Magno, Giulia
    Emhardt, Alica-Joana
    Holzem, Alessandra M. E.
    dos Santos, David M. Cordas
    Schmidt, Christian
    Griesshammer, Stefanie
    Frolich, Lisa
    Kobold, Sebastian
    von Bergwelt-Baildon, Michael
    Rejeski, Kai
    Subklewe, Marion
    HEMASPHERE, 2025, 9 (01):
  • [26] CAR T Cell Therapy Directed against CD19 in Patients with B-cell Lymphoma after an Allogeneic Hematopoietic Stem Cell Transplantation (AlloHCT) is Feasible and Safe
    Schubert, Maria-Luisa
    Dietrich, Sascha
    Schmitt, Anita
    Pavel, Petra
    Kunz, Alexander
    Bondong, Andrea
    Wegner, Mandy
    Stadtherr, Peter
    Jung, Susanne
    Stilgenbauer, Stephan
    Ho, Anthony
    Mueller-Tidow, Carsten
    Schmitt, Michael
    Dreger, Peter
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 246 - 247
  • [27] Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.
    Cappell, Kathryn
    Sherry, Richard Mark
    Yang, James C.
    Goff, Stephanie L.
    Vanasse, Danielle
    McIntyre, Lori
    Rosenberg, Steven A.
    Kochenderfer, James N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
    Chen, George
    Herr, Megan
    Nowak, Jan
    Ho, Christine
    Almyroudis, Nikolaos
    Attwood, Kristopher
    Bonnewell, John
    Walsh, Marissa
    Segal, Brahm
    Ross, Maureen
    McCarthy, Philip
    Hahn, Theresa
    HAEMATOLOGICA, 2023, 108 (02) : 615 - 620
  • [29] Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
    Bukhari, Ali
    El Chaer, Firas
    Koka, Rima
    Singh, Zeba
    Hutnick, Elizabeth
    Ruehle, Kathleen
    Lee, Seung Tae
    Kocoglu, Mehmet H.
    Shanholtz, Carl
    Badros, Ashraf
    Hardy, Nancy
    Yared, Jean
    Rapoport, Aaron P.
    Dahiya, Saurabh
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E273 - E275
  • [30] SALVAGE THERAPIES AND OUTCOMES OF PATIENTS WITH RELAPSE OF B-ALL AFTER CD19 CAR T-CELL THERAPY
    Friedes, Barbara
    DiNofia, Amanda
    Li, Yimei
    Iannone, Emma
    Rheingold, Susan
    Leahy, Allison Barz
    Wray, Lisa
    Callahan, Colleen
    Baniewicz, Diane
    Liu, Hongyan
    Getz, Kelly
    Aplenc, Richard
    Maude, Shannon
    Grupp, Stephan
    Myers, Regina
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S54 - S54
12345